Varex Imaging Corp — Form 8-K
Filed August 10, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 72/100
What the filing says
Varex reported Q3 FY2026 revenues of $211M (up 4% YoY), with Medical revenue $134M and Industrial revenue $77M. GAAP net income was $0.37/share; non-GAAP EPS $0.31 vs. $0.13 prior year. Q3 included a $17M tariff refund from U.S. Customs, with a $7M revenue reduction for customer reimbursements, netting ~$10M gross profit benefit. Cash declined to $99M from $155M at FY2025 end due to debt redemption/refinancing in March and increased working capital. Critically, the company cancelled its earnings call and suspended forward guidance due to the pending acquisition by Teledyne Technologies Incorporated.
Why this rating
Pending Teledyne acquisition is transformational but creates uncertainty; cancellation of guidance and call signals transaction pendency. Q3 fundamentals modest (4% growth, ~$211M revenue is 62% of $339M market cap); tariff recovery is temporary, non-recurring. Material relative to size but deal status dominates outlook.
See more from August 10, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.